Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
33 studies found for:    " August 21, 2013":" September 20, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting CCTG 593: Testing and Linkage to Care
Conditions: HIV Positive;   HIV Seronegative
Intervention: Behavioral: Linkage to PrEP or Care
2 Recruiting A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.
Condition: HIV Infections
Intervention: Biological: rAAV1-PG9DP
3 Completed Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen
Condition: HIV Disease
Intervention: Drug: Stribild (elvitegravir, cobicistat, emtricitabine and tenofovir)
4 Recruiting Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Condition: HIV Infections
Interventions: Drug: Romidepsin;   Drug: Placebo for RMD: 0.9% sodium chloride for injection
5 Active, not recruiting CCTG 594: Engagement and Retention in Care for HIV+
Conditions: Patient Adherence;   HIV Positive
Intervention: Behavioral: SoC + ALERT Intervention
6 Completed
Has Results
A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)
Condition: HIV Infections
Interventions: Drug: Raltegravir (ISENTRESS™);   Drug: MAALOX (MAL)
7 Completed Determining the Barriers and Motivations to Clinical Trial Participation
Condition: HIV
Intervention:
8 Completed Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation Study
Conditions: HIV;   Human Immunodeficiency Virus
Intervention: Drug: Disulfiram
9 Recruiting Patient-Centered Disclosure Intervention for HIV-Infected Children
Condition: HIV
Intervention: Behavioral: HADITHI Intervention
10 Active, not recruiting ENGAGE4HEALTH: A Combination Intervention Strategy for Linkage and Retention in Mozambique
Condition: HIV
Interventions: Other: Point of care CD4+ after HIV diagnosis;   Other: Accelerated ART initiation;   Behavioral: SMS appointment reminders;   Other: Non-cash Financial Incentives
11 Active, not recruiting Evaluating Safety and Effectiveness of Low-Dose Methotrexate at Reducing Inflammation in HIV-Infected Adults Taking Antiretroviral Medications
Condition: HIV Infections
Interventions: Drug: Methotrexate (MTX);   Drug: Placebo;   Dietary Supplement: Folic acid
12 Completed Vertical Transmission Study
Condition: HIV
Intervention: Behavioral: Infant feeding counselling and support
13 Active, not recruiting Zinc for HIV Disease Among Alcohol Users - an RCT in the Russia ARCH Cohort
Conditions: HIV Infection;   Alcohol Use
Interventions: Dietary Supplement: Zinc gluconate;   Dietary Supplement: Placebo
14 Active, not recruiting The Impact of Mentor Mothers on PMTCT Service Outcomes in Nigeria
Condition: HIV
Intervention: Behavioral: Trained Mentor Mother and Supervisor
15 Active, not recruiting Strategies to Optimize Antiretroviral Therapy Services for Maternal & Child Health: the MCH-ART Study
Condition: HIV
Intervention: Other: MCH-focused ART services
16 Recruiting Observational Study of HIV-associated Neurocognitive Disorder
Conditions: HIV Associated Neurocognitive Disorder;   Human Immunodeficiency Virus
Intervention:
17 Completed An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial (MTN-003)
Condition: HIV Prevention
Intervention: Behavioral: Focus Group Discussions and In-Depth Interviews
18 Recruiting Effect of Cenicriviroc on HIV Neurocognitive Impairment
Conditions: AIDS Dementia Complex;   HIV-1-Associated Cognitive Motor Complex;   Human Immunodeficiency Virus
Intervention: Drug: cenicriviroc
19 Completed Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials
Conditions: HIV Infection;   Malignant Neoplasm;   Precancerous Condition
Intervention: Other: questionnaire administration
20 Active, not recruiting Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
Condition: HIV-1 Infection
Intervention: Drug: Pegylated Interferon alpha 2b

   Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.